212 related articles for article (PubMed ID: 22963039)
1. The elevation of serum napsin A in idiopathic pulmonary fibrosis, compared with KL-6, surfactant protein-A and surfactant protein-D.
Samukawa T; Hamada T; Uto H; Yanagi M; Tsukuya G; Nosaki T; Maeda M; Hirano T; Tsubouchi H; Inoue H
BMC Pulm Med; 2012 Sep; 12():55. PubMed ID: 22963039
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
Xue M; Guo Z; Cai C; Sun B; Wang H
Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
[TBL] [Abstract][Full Text] [Related]
3. Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis.
Yoshikawa T; Otsuka M; Chiba H; Ikeda K; Mori Y; Umeda Y; Nishikiori H; Kuronuma K; Takahashi H
BMC Pulm Med; 2020 Jan; 20(1):27. PubMed ID: 32005219
[TBL] [Abstract][Full Text] [Related]
4. Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis.
Hamai K; Iwamoto H; Ishikawa N; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N; Kohno N
Dis Markers; 2016; 2016():4759040. PubMed ID: 27293304
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
[TBL] [Abstract][Full Text] [Related]
6. Advances in the study of biomarkers of idiopathic pulmonary fibrosis in Japan.
Huang H; Peng X; Nakajima J
Biosci Trends; 2013 Aug; 7(4):172-7. PubMed ID: 24056167
[TBL] [Abstract][Full Text] [Related]
7. Serum surfactant protein-A, but not surfactant protein-D or KL-6, can predict preclinical lung damage induced by smoking.
Kobayashi H; Kanoh S; Motoyoshi K
Biomarkers; 2008 Jun; 13(4):385-92. PubMed ID: 18595202
[TBL] [Abstract][Full Text] [Related]
8. Serum concentrations of Krebs von den Lungen-6, surfactant protein D, and matrix metalloproteinase-2 as diagnostic biomarkers in patients with asbestosis and silicosis: a case-control study.
Xue C; Wu N; Li X; Qiu M; Du X; Ye Q
BMC Pulm Med; 2017 Nov; 17(1):144. PubMed ID: 29149883
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of changes in the serum levels of Krebs von den Lungen-6 and surfactant protein-D over time as important biomarkers in idiopathic fibrotic nonspecific interstitial pneumonia.
Yamakawa H; Hagiwara E; Ikeda S; Iwasawa T; Otoshi R; Tabata E; Okuda R; Sekine A; Baba T; Iso S; Okudela K; Takemura T; Ogura T
Respir Investig; 2019 Sep; 57(5):422-429. PubMed ID: 31003951
[TBL] [Abstract][Full Text] [Related]
10. Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study.
Huang TH; Kuo CW; Chen CW; Tseng YL; Wu CL; Lin SH
BMC Pulm Med; 2021 May; 21(1):165. PubMed ID: 33992083
[TBL] [Abstract][Full Text] [Related]
11. Serum surfactant protein D as a predictive biomarker for the efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis: a post-hoc analysis of the phase 3 trial in Japan.
Ikeda K; Chiba H; Nishikiori H; Azuma A; Kondoh Y; Ogura T; Taguchi Y; Ebina M; Sakaguchi H; Miyazawa S; Suga M; Sugiyama Y; Nukiwa T; Kudoh S; Takahashi H;
Respir Res; 2020 Nov; 21(1):316. PubMed ID: 33256760
[TBL] [Abstract][Full Text] [Related]
12. Serum SP-A and KL-6 levels can predict the improvement and deterioration of patients with interstitial pneumonia with autoimmune features.
Wang J; Zheng P; Huang Z; Huang H; Xue M; Liao C; Sun B; Zhong N
BMC Pulm Med; 2020 Dec; 20(1):315. PubMed ID: 33267857
[TBL] [Abstract][Full Text] [Related]
13. Significance of serum vascular endothelial growth factor level in patients with idiopathic pulmonary fibrosis.
Ando M; Miyazaki E; Ito T; Hiroshige S; Nureki SI; Ueno T; Takenaka R; Fukami T; Kumamoto T
Lung; 2010 Jun; 188(3):247-52. PubMed ID: 20066538
[TBL] [Abstract][Full Text] [Related]
14. Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma.
Hant FN; Ludwicka-Bradley A; Wang HJ; Li N; Elashoff R; Tashkin DP; Silver RM;
J Rheumatol; 2009 Apr; 36(4):773-80. PubMed ID: 19286849
[TBL] [Abstract][Full Text] [Related]
15. Impact of serum SP-A and SP-D levels on comparison and prognosis of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
Wang K; Ju Q; Cao J; Tang W; Zhang J
Medicine (Baltimore); 2017 Jun; 96(23):e7083. PubMed ID: 28591049
[TBL] [Abstract][Full Text] [Related]
16. Serum heat shock protein 47 levels are elevated in acute exacerbation of idiopathic pulmonary fibrosis.
Kakugawa T; Yokota S; Ishimatsu Y; Hayashi T; Nakashima S; Hara S; Sakamoto N; Kubota H; Mine M; Matsuoka Y; Mukae H; Nagata K; Kohno S
Cell Stress Chaperones; 2013 Sep; 18(5):581-90. PubMed ID: 23435730
[TBL] [Abstract][Full Text] [Related]
17. The overexpression of peroxiredoxin-4 affects the progression of idiopathic pulmonary fibrosis.
Hanaka T; Kido T; Noguchi S; Yamada S; Noguchi H; Guo X; Nawata A; Wang KY; Oda K; Takaki T; Izumi H; Ishimoto H; Yatera K; Mukae H
BMC Pulm Med; 2019 Dec; 19(1):265. PubMed ID: 31888585
[TBL] [Abstract][Full Text] [Related]
18. Serum heat shock protein 47 levels in patients with drug-induced lung disease.
Kakugawa T; Yokota S; Ishimatsu Y; Hayashi T; Nakashima S; Hara S; Sakamoto N; Matsuoka Y; Kubota H; Mine M; Mukae H; Nagata K; Kohno S
Respir Res; 2013 Nov; 14(1):133. PubMed ID: 24256690
[TBL] [Abstract][Full Text] [Related]
19. The usefulness of KL-6 and SP-D for the diagnosis and management of chronic hypersensitivity pneumonitis.
Okamoto T; Fujii M; Furusawa H; Tsuchiya K; Miyazaki Y; Inase N
Respir Med; 2015 Dec; 109(12):1576-81. PubMed ID: 26481343
[TBL] [Abstract][Full Text] [Related]
20. Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis.
Kinder BW; Brown KK; McCormack FX; Ix JH; Kervitsky A; Schwarz MI; King TE
Chest; 2009 Jun; 135(6):1557-1563. PubMed ID: 19255294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
